ALVAC-CEA vaccine

ALVAC-CEA vaccine is a cancer vaccine containing a canary pox virus (ALVAC) combined with the carcinoembryonic antigen (CEA) human gene.

A phase I trial in 118 patients showed safety in humans.^[1]

References

This article incorporates public domain material from the U.S. National Cancer Institute document "Dictionary of Cancer Terms".

Development

Classes

Administration

Vaccines

Bacterial	Anthrax Brucellosis Cholera^# Diphtheria^# Hib^# Lyme disease^‡ Meningococcus^# MeNZB NmVac4-A/C/Y/W-135 Pertussis^# Plague Pneumococcal^# PCV PPSV Q fever Tetanus^# Tuberculosis BCG^# Typhoid^# Ty21a ViCPS Typhus combination: DTwP/DTaP

Viral	Adenovirus Flu^# H1N1 (Pandemrix) LAIV Hantavirus Hepatitis A^# Hepatitis B^# Hepatitis E HPV Cervarix Gardasil Japanese encephalitis^# Measles^# Mumps^# Mumpsvax Polio^# Sabin Salk Rabies^# Rotavirus^# Rubella^# Smallpox Dryvax Tick-borne encephalitis Varicella zoster chicken pox^# shingles Yellow fever^# combination: MMR MMRV research: Chikungunya Cytomegalovirus Dengue Ebola Epstein–Barr virus Hepatitis C HIV

Protozoan	research: Malaria Trypanosomiasis

Helminthiasis	research: Hookworm Schistosomiasis

Other	Cancer vaccines ALVAC-CEA Hepatitis B^# HPV Cervarix Gardasil NicVAX TA-CD TA-NIC

Controversy

See also

Index of bacterial disease

Description	Bacteria classification Growth media

Disease	Gram-positive firmicutes Gram-positive actinobacteria Gram-negative proteobacteria Gram-negative non-proteobacteria Cholera Tuberculosis

Treatment	Antibiotics cell wall nucleic acid mycobacteria protein synthesis other Antibodies Vaccines

Index of viral disease

Description	Virus classification Viral proteins

Disease	Systemic HIV and AIDS influenza Cutaneous Zoster Human papillomavirus Zoonotic Symptoms and signs

Treatment	Drugs antiretroviral DNA RNA Vaccines